Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han Yun

Showing results (271-280 of 305) with videos related to

Pageof 31
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 23, 2013
[Hematopoietic reconstitution on the prognosis of hematological malignancies after allogeneic hematopoietic stem cell transplantation]Yan Zhang, Han-Yun Ren, Zhi-Xiang Qiu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 9, 2012
[Study on chronic health conditions and its related risk factors in recipients after hematopoietic stem cell transplantation]Jian-jun Song, Han-yun Ren, Zhi-xiang Qiu, et al.
Nutrition Research (New York, N.Y.)|March 12, 2018
Arctigenin protects against steatosis in WRL68 hepatocytes through activation of phosphoinositide 3-kinase/protein kinase B and AMP-activated protein kinase pathwaysKung-Yen Chen, Jui-An Lin, Han-Yun Yao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 12, 2012
[Clinical investigation of primary amyloidosis with autologous hematopoietic stem cell transplantation]Zhi-xiang Qiu, Mang-ju Wang, Li-hong Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 3, 2010
[Efficacy analysis of sequential treatment with chemotherapy, ATRA and As(2)O(3) for acute promyelocytic leukemia]Xiang-Juan Ma, Han-Yun Ren, Xi-Nan Cen, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 17, 2019
[Preliminary Study on the Characteristic of Plasma Cytokine Profiles in Patients with Idiopathic Multicentric Castleman Diseases]Ning Ma, Hui-Hui Liu, Wei Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 1, 2013
[Combination of rituximab with autologous peripheral blood stem cell transplantation for treatment of diffuse large B-cell lymphoma: a single-center experience]Ze-yin Liang, Xi-nan Cen, Zhi-xiang Qiu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 28, 2013
[Prognostic implications of hematopoietic cell transplantation-specific comorbidity index on non-relapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation]Chun-yue Wang, Han-yun Ren, Zhi-xiang Qiu, et al.
Chinese Medical Journal|July 16, 2019
Comparison of outcomes after human leukocyte antigen-matched and haploidentical hematopoietic stem-cell transplantation for multiple myelomaYao Chen, Wei-Jun Fu, Lan-Ping Xu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 29, 2018
[Incidence of Bone Marrow Involvement in Different Pathological Type Lymphoma Patients]Qing Chen, Lu-Ting Zhu, Xi-Nan Cen, et al.
Pageof 31

Showing results (271-280 of 305) with videos related to

Sort By:
Pageof 31
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 23, 2013
[Hematopoietic reconstitution on the prognosis of hematological malignancies after allogeneic hematopoietic stem cell transplantation]Yan Zhang, Han-Yun Ren, Zhi-Xiang Qiu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 9, 2012
[Study on chronic health conditions and its related risk factors in recipients after hematopoietic stem cell transplantation]Jian-jun Song, Han-yun Ren, Zhi-xiang Qiu, et al.
Nutrition Research (New York, N.Y.)|March 12, 2018
Arctigenin protects against steatosis in WRL68 hepatocytes through activation of phosphoinositide 3-kinase/protein kinase B and AMP-activated protein kinase pathwaysKung-Yen Chen, Jui-An Lin, Han-Yun Yao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 12, 2012
[Clinical investigation of primary amyloidosis with autologous hematopoietic stem cell transplantation]Zhi-xiang Qiu, Mang-ju Wang, Li-hong Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 3, 2010
[Efficacy analysis of sequential treatment with chemotherapy, ATRA and As(2)O(3) for acute promyelocytic leukemia]Xiang-Juan Ma, Han-Yun Ren, Xi-Nan Cen, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 17, 2019
[Preliminary Study on the Characteristic of Plasma Cytokine Profiles in Patients with Idiopathic Multicentric Castleman Diseases]Ning Ma, Hui-Hui Liu, Wei Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 1, 2013
[Combination of rituximab with autologous peripheral blood stem cell transplantation for treatment of diffuse large B-cell lymphoma: a single-center experience]Ze-yin Liang, Xi-nan Cen, Zhi-xiang Qiu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 28, 2013
[Prognostic implications of hematopoietic cell transplantation-specific comorbidity index on non-relapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation]Chun-yue Wang, Han-yun Ren, Zhi-xiang Qiu, et al.
Chinese Medical Journal|July 16, 2019
Comparison of outcomes after human leukocyte antigen-matched and haploidentical hematopoietic stem-cell transplantation for multiple myelomaYao Chen, Wei-Jun Fu, Lan-Ping Xu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 29, 2018
[Incidence of Bone Marrow Involvement in Different Pathological Type Lymphoma Patients]Qing Chen, Lu-Ting Zhu, Xi-Nan Cen, et al.
Pageof 31